Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 57.70
-0.50 (-0.86%)
At close: Aug 18, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.35 billion as of August 18, 2026. Its market cap has decreased by -10.11% in one year.
Market Cap
3.35B
Enterprise Value
3.24B
Revenue
265.54M
Ranking
n/a
PE Ratio
112.09
Stock Price
57.70
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.35B, an increase of 140.76%. That is a compound annual growth rate of 53.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 2.79B | -22.21% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 20.96B |
| Elixiron Immunotherapeutics (Cayman) Limited | 11.00B |
| Uwell Biopharma | 7.47B |
| Intelligene | 7.05B |
| Tripartite Therapeutics | 4.72B |
| Obigen Pharma | 3.97B |
| BIONET Therapeutics | 2.10B |
| FullHope Biomedical | 1.08B |